This inventor holds 1 USPTO granted patent. Top assignee: Genmab Holding B.v.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: The Innovations of Ronald Taylor
Introduction
Ronald Taylor is a notable inventor recognized for his contributions to the field of biotechnology. He has made significant strides in the development of monoclonal antibodies, particularly in relation to anti-CD37 antibodies. His work has implications for various therapeutic applications.
Latest Patents
Ronald Taylor holds a patent titled "Methods of Use of Anti-CD37 Antibodies, Monoclonal Anti-CD37 Antibodies." This patent showcases his innovative approach to utilizing these antibodies in medical treatments. He has 1 patent to his name, reflecting his commitment to advancing medical science.
Career Highlights
Taylor is currently employed at Genmab Holding B.V., a leading biotechnology company focused on developing differentiated antibody therapeutics for the treatment of cancer. His role at Genmab has allowed him to collaborate with other talented professionals in the field.
Collaborations
Some of his notable coworkers include Simone Oostindie and Frank Beurskens. Their collective expertise contributes to the innovative environment at Genmab, fostering advancements in antibody research and development.
Conclusion
Ronald Taylor's work in the field of monoclonal antibodies exemplifies the impact of innovation in biotechnology. His contributions continue to pave the way for new therapeutic options in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile